Tietueen sitaatit

APA-viite (7. p.)
Chen, C., Sun, P., & Long, J. (2022). Robust and durable response to first-line treatment of pembrolizumab combined with chemotherapy in two patients with metastatic thymic squamous cell carcinoma: Case report. Frontiers Media S.A.
Chicago-viite (17. p.)
Chen, Cui, Peng Sun, ja Jianting Long. Robust and Durable Response to First-line Treatment of Pembrolizumab Combined with Chemotherapy in Two Patients with Metastatic Thymic Squamous Cell Carcinoma: Case Report. Frontiers Media S.A, 2022.
MLA-viite (9. p.)
Chen, Cui, et al. Robust and Durable Response to First-line Treatment of Pembrolizumab Combined with Chemotherapy in Two Patients with Metastatic Thymic Squamous Cell Carcinoma: Case Report. Frontiers Media S.A, 2022.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.